Unverified50% confidenceEventExact time
Insilico Medicine reported in 2025 the Phase 2a clinical trial results of an AI-discovered drug for pulmonary fibrosis.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
10/15/2026
First Seen
Valid until: 1/13/2027
Sources
Related Entities
Related Claims
UnverifiedInsilico Medicine于2023年将其AI设计的候选药物推进至临床II期试验，成为首个完全由AI设计并进入临床阶段的药物分子75% similarUnverified2023年FDA发布了AI/ML药物开发讨论文件，但仅是初步探索55% similarUnverified2024年多家制药公司已将AI生成的候选分子推入针对神经退行性疾病的临床试验阶段54% similarUnverified2023年10月的《布莱切利宣言》首次在政府间层面确认AI在生物领域的潜在风险51% similarUnverifiedAI在2023年辅助发现了新型抗生素50% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1034377API
curl https://kongchang.com/api/v1/knowledge/claims/1034377MCP
get_claim(id=1034377)